1/n: 1 month ago the team at @RecursionPharma partnered with a Biosafety Level 3 Lab to assess if they could 1) phonemically characterize in vitro COVID19 and 2) run high throughput screens to find therapeutic candidatures as potential cures
https://t.co/oasEokH2nB
We just released a preprint article that we are proud to contribute to the growing body of data being used to combat COVID-19. We want to express our gratitude to the team who put this in vitro work together in just 4 weeks under challenging circumstances.
https://t.co/lmcp436dH2